Cosmos Health Reports Record $54.3M Nine-Month Revenue

Cosmos Health reported preliminary nine-month 2026 revenue of about $54.3 million, up 19% from the same period a year earlier, and preliminary third-quarter revenue of $17.4 million, slightly above the prior-year quarter. The company said each of the first three quarters set a quarterly revenue record, with growth attributed to its contract manufacturing, pharmaceutical distribution and proprietary-brand businesses. It reaffirmed its outlook for 2026 revenue to exceed $90 million and said it expects the fourth quarter to be its strongest yet. The figures are preliminary and unaudited.